APPROVED trumps Hope and Hype.
The Hep C market is huge.
Over 60M pap smears are taken annually in the US.
GTHP's biophotonic cervical cancer scan is noninvasive, more accurate and produces instant test results.
FDA approval is expected any day.
It's already approved in EU, canada, Mexico, Asia.
International sales are ramping up. See the recent news on shipments to China and Indonesia.
The market cap is only $20M.
EXAS, with an inferior product (fecal matter needs to be sent to a lab for analysis), saw its market cap soar to $2 billion upon the approval of it's colorectal cancer scan recently
The new CEO is from GE Diagnostics and Abbott Healthcare.
The device sells for $25K and the disposable used in each scan sells for $30 (a lot less than the lab fee.)
90% profit margins on the disposable = $25 profit per scan.
In the US: 60M X $25 = $1.5 Billion profit potential.
Then there is EU, China, Indonesia, South America, Africa, Canada..............
Do your finances a favor and switch to GTHP --- get over 25 shares of GTHP for each NVGN share.
The potential is huge .... GTHP's biophotonics is technology superior to pap smears.
When the 60M annual pap smears in the US are replaced by LuViva..... the profit to GTHP is $25 on the disposable used in each scan X 60M tests = $1.5 BILLION.
Then there is China, Indonesia, EU, Canada, South America, Africa...................
You should be buying GTHP.
FDA approval in May ----- recently approved in EU, Canada, Mexico, Asia.
APPROVED trumps Hope and Hype ..... especially at a lower market cap.
What were yoou thinking?
I checked it out ,,,,,, it actually looks pretty good.
The devices sells for $25K and the disposable for $30 which is a lot less than lab fees for paps.
Potential profit in the US is $1.5 billion plus $9 billion in China.
Then there is Indonesia, Canada, South America, Africa, EU .......
I checked it out .... it actually looks pretty good.
The device sells for $25K and the disposable for $30 which is a lot less than the lab fee for paps.
The 90% profit margin = potential profit of $1.5 BILLION in the US.
$9 billion in China, $1.5 Billion in Indonesia .... then there's EU, South America, Africa, Canada.......
Run fast like Forest Gump from scam.
You must have said the same thing when VLTC was at .73 in February.
Pssssssssssst: Buy low, Sell high.
China stocks are sketchy with questionable accounting practices.
Buy US companies that sell to China.
Orders received from China and Indonesia - see the recent news.